Literature DB >> 9543670

Comparison of immunohistochemical staining of the novel antibody melan-A with S100 protein and HMB-45 in malignant melanoma and melanoma variants.

K Blessing1, D S Sanders, J J Grant.   

Abstract

AIMS: The staining pattern of the recently described antibody melan-A was compared with those of S100 protein and HMB-45 in a variety of melanocytic lesions to assess the specificity and sensitivity of these antibodies. METHODS AND
RESULTS: Immunohistochemical staining of paraffin sections of a range of melanocytic lesions was carried out following a high temperature antigen retrieval technique. The pattern and intensity of staining was semiquantitatively scored. S100 remains the most sensitive marker of melanocytic differentiation being diffusely positive in all benign and all primary and secondary malignant lesions including naevoid melanomas, and in most desmoplastic/spindle cell melanomas. Of the two more specific melanocytic markers melan-A stains the majority of benign and malignant lesions diffusely but with occasional patchy positivity only in some secondary melanoma deposits and with little staining of desmoplastic/spindle cell melanomas. HMB-45 is the least sensitive of the three showing little positivity of benign mature naevus cells, only variable patchy positivity of primary and secondary melanoma cells and limited positivity in naevoid, desmoplastic and metastatic melanomas.
CONCLUSIONS: Melan-A is a useful addition to antibody panels as it is apparently specific for melanocytic lesions and is more sensitive than HMB-45; however, it has less value than S100 in the detection of spindle cell and desmoplastic melanomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9543670     DOI: 10.1046/j.1365-2559.1998.00312.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  27 in total

1.  Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.

Authors:  G E Orchard
Journal:  Histochem J       Date:  2000-08

2.  Immunohistochemistry in mohs micrographic surgery: a review of the literature.

Authors:  Novie Sroa; Shannon Campbell; Larisa Ravitskiy
Journal:  J Clin Aesthet Dermatol       Date:  2009-07

3.  Value of A103 (melan-A) immunostaining in the differential diagnosis of ovarian sex cord stromal tumours.

Authors:  C J Stewart; C L Nandini; J A Richmond
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

4.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

5.  A rare case of amelanotic malignant melanoma in the oral region: Clinical investigation and immunohistochemical study.

Authors:  Yuichi Ohnishi; Masahiro Watanabe; Tomoko Fujii; Noriko Sunada; Hitoshi Yoshimoto; Hirohito Kubo; Masahiro Wato; Kenji Kakudo
Journal:  Oncol Lett       Date:  2015-10-20       Impact factor: 2.967

6.  The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).

Authors:  K S Clarkson; I C Sturdgess; A J Molyneux
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

7.  A practical and comprehensive immunohistochemical approach to the diagnosis of superficial soft tissue tumors.

Authors:  Wael Al-Daraji; Ehab Husain; Bettena G Zelger; Bernhard Zelger
Journal:  Int J Clin Exp Pathol       Date:  2008-06-10

8.  Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.

Authors:  Hollis Viray; William R Bradley; Kurt A Schalper; David L Rimm; Bonnie E Gould Rothberg
Journal:  Arch Pathol Lab Med       Date:  2013-08       Impact factor: 5.534

9.  MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.

Authors:  Jinyan Du; Arlo J Miller; Hans R Widlund; Martin A Horstmann; Sridhar Ramaswamy; David E Fisher
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

10.  Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.

Authors:  Yasufumi Goto; Soldano Ferrone; Takaaki Arigami; Minoru Kitago; Atsushi Tanemura; Eiji Sunami; Sandy L Nguyen; Roderick R Turner; Donald L Morton; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.